ACXP News and Press, Acurx Pharmaceuticals Inc. From 10/26/22

Acurx Announces Scientific Oral and Poster Presented at IDWeek 2022 PR Newswire Presents research on ibezapolstat's selective activity on healthy bacteria within the gut microbiome in the treatment of C. difficile Infection (CDI) Emerging ibezapolstat microbiom...

Acurx Announces Scientific Oral and Poster Presentations at IDWeek PR Newswire New emerging, favorable microbiome data to be presented from previously completed Ph1 healthy volunteers and Ph2a patients with C. difficile Infection clinical trials Extends researc...

NEW YORK, Oct. 10, 2022 (GLOBE NEWSWIRE) -- FMW Media's New to The Street TV , a nationally syndicated televised show, announces episode #394, airing tonight, Monday, October 10, 2022, at 10:30 PM on the Fox Business Network . New to The Street's 394th televised ep...

NEW YORK, Oct. 07, 2022 (GLOBE NEWSWIRE) -- FMW Media's New to The Street / Newsmax announces the televised line-up of its national syndicated 1-hour show, Sunday, October 9, 2022, airing time 10-11 AM ET. New to The Street's 393rd episode line-up features the ...

NEW YORK, Sept. 26, 2022 (GLOBE NEWSWIRE) -- FMW Media’s New to The Street TV , a nationally syndicated TV show, announces episode #390 airing tonight, Monday, September 26, 2022, at 10:30 PM PT on the Fox Business Network. New to The Street’...

NEW YORK, Sept. 23, 2022 (GLOBE NEWSWIRE) -- FMW Media’s New to The Street TV announces broadcasting its sponsored program business show Saturday, September 24, 2022, on Bloomberg TV at 6:00 PM ET . New to The Street’s TV episode #388 will...

NEW YORK, Sept. 16, 2022 (GLOBE NEWSWIRE) -- FMW Media's New to The Street / Newsmax TV announces the broadcasting line-up of its national syndicated 1-hour TV show this Sunday, September 18, 2022, airing time 10-11 AM ET. New to The Street's 386th TV episode l...

Ridinilazole failed to meet the endpoint of superiority over vancomycin in phase 3 trials. Summit Therapeutics has a preclinical antibiotic for Enterobacteriaceae, an infection where there is a clear need for novel therapeutics. Antibiotics are an extremely difficult segment of th...

Acurx Pharmaceuticals, Inc. (ACXP) Q2 2022 Earnings Conference Call August 16, 2022, 08:30 AM ET Company Participants Robert Shawah - CFO David Luci - CEO Conference Call Participants Jim Molloy - Alliance Global Partners Presentation Operat...

Acurx Pharmaceuticals press release ( NASDAQ: ACXP ): Q2 GAAP EPS of -$0.26. The company ended the second quarter on Jun 30, 2022, with cash totaling $9.1M compared to $13.1M as of Dec. 31, 2021. For further details see: Acurx Pharmaceuticals GAAP EPS of -$0.26 ...